Showing 1 - 10 of 16
Can protests cause political change, or are they merely symptoms of underlying shifts in policy preferences? We address this question by studying the Tea Party movement in the United States, which rose to prominence through coordinated rallies across the country on Tax Day, April 15, 2009. We...
Persistent link: https://www.econbiz.de/10011211936
Can protests cause political change, or are they merely symptoms of underlying shifts in policy preferences?
Persistent link: https://www.econbiz.de/10010949200
In this paper, we estimate the size of the externalities produced by big-box retail stores for other establishments and explore the effect of the externalities on local government policy.
Persistent link: https://www.econbiz.de/10011145253
We document the tight link between increased levels of economic and policy uncertainty and unemployment at the state-level during the 2007-2009 recession.
Persistent link: https://www.econbiz.de/10011145273
In this paper, we estimate the size of the externalities produced by big-box retail stores for other establishments and explore the effect of the externalities on local government policy.
Persistent link: https://www.econbiz.de/10010842032
We document the tight link between increased levels of economic and policy uncertainty and unemployment at the state-level during the 2007-2009 recession.
Persistent link: https://www.econbiz.de/10010842033
Can protests cause political change, or are they merely symptoms of underlying shifts in policy preferences?
Persistent link: https://www.econbiz.de/10010842041
We propose a model of voter decision-making in proportional representation systems: ultra-rational strategic voters construct expectations of coalitions and policy outcomes based on expected seat distributions and vote to maximize their expected utility from the implemented policy.
Persistent link: https://www.econbiz.de/10011124240
Can access to regulators provide operational benefits to firms?
Persistent link: https://www.econbiz.de/10011145276
We describe the broad range of uncertainties faced by the developers of medical technologies. Empirically, we estimate the asset market incidence of the realization  of two such of uncertainties experienced by the biotechnology firm Myriad Genetics, Inc.
Persistent link: https://www.econbiz.de/10011273205